Irhythm Technologies, INC Form 4 insider transactions

Quentin S. Blackford, President and CEO and a Director of iRhythm Technologies, Inc., sold 26,859 shares of common stock on August 7, 2026 for $124.65 per share.

Patrick Michael Murphy, CBO and CLO of iRhythm Technologies, Inc., sold 7,093 shares of common stock on August 7, 2026 for $124.65 per share.

Chad Patterson, CHIEF COMM & PRODUCT OFFICER of iRhythm Technologies, Inc., sold 7,093 shares of common stock on August 7, 2026 for $124.65 per share.

Sumi Shrishrimal, EVP, Chief Risk Officer of iRhythm Technologies, Inc., sold 5,372 shares of common stock on August 7, 2026 for $124.65 per share.

Minang Turakhia, CHIEF MED/SCI OFCR EVP ADVTECH of iRhythm Technologies, Inc., sold 7,093 shares of common stock on August 7, 2026 for $124.65 per share.

Julianne Rodda, EVP, CHIEF PEOPLE OFFICER of iRhythm Technologies, Inc., sold 2,112 shares of common stock on August 3, 2026 for $122.12 per share.

Chad Patterson, CHIEF COMM & PRODUCT OFFICER of iRhythm Technologies, Inc., sold 2,712 shares of common stock on August 3, 2026 for $122.12 per share.

iRhythm Holdings executive Minang Turakhia sold 1,423 shares of common stock on July 2, 2026, for tax withholding purposes.

Sean Clinton Freeman of iRhythm Holdings, Inc. reported a sale of 918 common stock shares on July 2, 2026, for $124.71 per share.

iRhythm Holdings, Inc. reports a Form 4 filing detailing stock transactions by EVP, Chief Risk Officer Sumi Shrishrimal, including share acquisitions and sales for tax withholding.

iRhythm Holdings reports an acquisition of common stock by Chief Medical/Scientific Officer and EVP of Advanced Technology, Minang Turakhia, under the company's Employee Stock Purchase Plan.

Chad Patterson, Chief Commercial & Product Officer at iRhythm Holdings, Inc., has acquired 177 shares of common stock through an employee stock purchase plan.

iRhythm Holdings, Inc. reports an acquisition of common stock by EVP Sean Clinton Freeman under the company's Employee Stock Purchase Plan.

iRhythm Holdings President and CEO Quentin S. Blackford reported the acquisition of 178 shares of common stock through the company's Employee Stock Purchase Plan.

Director Cathleen Bairey Merz acquired 1,573 restricted stock units in iRhythm Holdings, Inc. as part of an equity grant.

Director Bruce G. Bodaken was granted 1,573 restricted stock units in iRhythm Holdings, Inc. as part of standard equity compensation.

Director Karen Ling acquired 1,573 restricted stock units in iRhythm Holdings, Inc. as part of an equity compensation grant.

Director Karen McGinnis was granted 1,573 restricted stock units as part of iRhythm Holdings, Inc.'s equity compensation program.

Director Kevin O'Boyle was granted 1,573 restricted stock units as part of iRhythm Holdings' equity compensation program.

Director Abhijit Y. Talwalkar was granted 1,573 restricted stock units in iRhythm Holdings, Inc. as part of standard equity compensation.

Director Brian Yoor was granted 1,573 restricted stock units as part of iRhythm Holdings, Inc.'s equity compensation program.

Director Abhijit Y. Talwalkar reported transactions involving the sale of iRhythm Holdings, Inc. common stock, executed under a pre-established Rule 10b5-1 trading plan.

iRhythm Holdings Chief Technology Officer, Lawrence Brian Lee, reported a sale of 1,014 shares of common stock on May 4, 2026, for tax withholding purposes.

iRhythm Holdings, Inc. Director Jason Patten was granted 2,218 restricted stock units, vesting over three years.

iRhythm Holdings EVP Mervin Smith sold 2,585 shares of common stock for $114.3 per share under a pre-arranged 10b5-1 trading plan.

iRhythm Holdings' Chief Medical/Scientific Officer, Minang Turakhia, sold 4,027 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Holdings' EVP, Chief Risk Officer, Sumi Shrishrimal, sold 2,830 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Holdings, Inc. EVP Mervin Smith sold 1,352 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Holdings' Chief Commercial & Product Officer, Chad Patterson, sold common stock to cover tax obligations related to RSU vesting.

An iRhythm Holdings, Inc. executive sold 4,357 shares of common stock to cover tax obligations related to RSU vesting.